,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2018,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),2/6,2.623727537628245e-05,0.0033846085235404,0,0,399.38,4212.791809360872,PTPRD;TRIO
1,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),3/120,0.0005546203099077218,0.035773009989048,0,0,21.213675213675213,159.04373443671076,PTPRD;TRIO;GFRA2
2,GO_Biological_Process_2018,regulation of synapse assembly (GO:0051963),2/35,0.0010159428226569,0.0436855413742467,0,0,48.339393939393936,333.15211605803563,PTPRD;ROBO2
140,GO_Biological_Process_2017b,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),2/13,0.00013564229227572053,0.0499163635574651,0,0,145.17818181818183,1292.8827507488604,PTPRD;TRIO
4,GO_Biological_Process_2018,axonogenesis (GO:0007409),3/223,0.0032832598560005,0.0847081042848133,0,0,11.223295454545454,64.18511191168743,ROBO2;LRFN2;GFRA2
3,GO_Biological_Process_2018,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/58,0.0027690078712777,0.0847081042848133,0,0,28.452857142857145,167.56644964163306,PTPRD;ROBO2
182,GO_Biological_Process_2017b,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction (GO:0052490),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,MECOM
196,GO_Biological_Process_2017b,central nervous system neuron differentiation (GO:0021953),2/159,0.0193541254358985,0.0939129031841749,0,0,10.097324840764331,39.83242868117013,PTPRD;ROBO2
195,GO_Biological_Process_2017b,anterior/posterior pattern specification involved in ureteric bud development (GO:0072099),1/14,0.0187409364492418,0.0939129031841749,0,0,59.05325443786983,234.8574522333829,ROBO2
194,GO_Biological_Process_2017b,metanephric smooth muscle tissue development (GO:0072208),1/13,0.0174135879176465,0.0939129031841749,0,0,63.9775641025641,259.14140891073174,ROBO2
193,GO_Biological_Process_2017b,metanephric cortex development (GO:0072214),1/13,0.0174135879176465,0.0939129031841749,0,0,63.9775641025641,259.14140891073174,ROBO2
192,GO_Biological_Process_2017b,metanephric capsule development (GO:0072213),1/12,0.0160845107297618,0.0939129031841749,0,0,69.7972027972028,288.2553656873905,ROBO2
191,GO_Biological_Process_2017b,mesenchymal cell apoptotic process involved in metanephros development (GO:1900200),1/12,0.0160845107297618,0.0939129031841749,0,0,69.7972027972028,288.2553656873905,ROBO2
181,GO_Biological_Process_2017b,metanephric pyramids development (GO:0072211),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,ROBO2
190,GO_Biological_Process_2017b,cell migration involved in metanephros development (GO:0035788),1/12,0.0160845107297618,0.0939129031841749,0,0,69.7972027972028,288.2553656873905,ROBO2
188,GO_Biological_Process_2017b,chemoattraction of axon (GO:0061642),2/142,0.0156429645074838,0.0939129031841749,0,0,11.333142857142857,47.12019355753685,ROBO2;GFRA2
187,GO_Biological_Process_2017b,axon extension involved in axon guidance (GO:0048846),2/139,0.0150238543897624,0.0939129031841749,0,0,11.583065693430656,48.62705397732546,ROBO2;GFRA2
186,GO_Biological_Process_2017b,regulation of metanephric glomerulus development (GO:0072298),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,ROBO2
185,GO_Biological_Process_2017b,negative regulation of autophagic cell death (GO:1904093),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,MECOM
184,GO_Biological_Process_2017b,cell differentiation involved in metanephros development (GO:0072202),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,ROBO2
183,GO_Biological_Process_2017b,negative regulation of retinal cell programmed cell death (GO:0046671),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,MECOM
197,GO_Biological_Process_2017b,astral microtubule depolymerization (GO:0060172),1/15,0.020066558464378,0.0939129031841749,0,0,54.832417582417584,214.3235039145759,STMN4
189,GO_Biological_Process_2017b,pattern specification involved in metanephros development (GO:0072268),1/12,0.0160845107297618,0.0939129031841749,0,0,69.7972027972028,288.2553656873905,ROBO2
198,GO_Biological_Process_2017b,metanephros morphogenesis (GO:0003338),1/15,0.020066558464378,0.0939129031841749,0,0,54.832417582417584,214.3235039145759,ROBO2
180,GO_Biological_Process_2017b,cell-cell signaling involved in metanephros development (GO:0072204),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,ROBO2
214,GO_Biological_Process_2017b,deoxyribose phosphate metabolic process (GO:0019692),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
213,GO_Biological_Process_2017b,carbamoyl phosphate metabolic process (GO:0070408),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
212,GO_Biological_Process_2017b,methanopterin-containing compound metabolic process (GO:2001115),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
211,GO_Biological_Process_2017b,phosphate-containing compound metabolic process (GO:0006796),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
210,GO_Biological_Process_2017b,xylulose 5-phosphate metabolic process (GO:0051167),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
209,GO_Biological_Process_2017b,D-tagatose 6-phosphate metabolic process (GO:2001058),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
208,GO_Biological_Process_2017b,O3-(N-acetylglucosamine-1-phosphoryl)-L-serine biosynthetic process (GO:0018425),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
207,GO_Biological_Process_2017b,nucleoside phosphate metabolic process (GO:0006753),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
206,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-) (GO:0061721),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
205,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde (GO:0061720),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
204,GO_Biological_Process_2017b,ureteric bud development (GO:0001657),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,ROBO2
203,GO_Biological_Process_2017b,metanephric collecting duct development (GO:0072205),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,ROBO2
202,GO_Biological_Process_2017b,1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
201,GO_Biological_Process_2017b,ribose phosphate metabolic process (GO:0019693),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
200,GO_Biological_Process_2017b,ureter part of ureteric bud development (GO:0035503),1/15,0.020066558464378,0.0939129031841749,0,0,54.832417582417584,214.3235039145759,ROBO2
199,GO_Biological_Process_2017b,ureteric bud morphogenesis (GO:0060675),1/15,0.020066558464378,0.0939129031841749,0,0,54.832417582417584,214.3235039145759,ROBO2
179,GO_Biological_Process_2017b,metanephric nephron development (GO:0072210),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,ROBO2
176,GO_Biological_Process_2017b,positive regulation of small GTPase mediated signal transduction (GO:0051057),2/136,0.0144157174812084,0.0939129031841749,0,0,11.844179104477613,50.21264136928573,TRIO;RHOJ
177,GO_Biological_Process_2017b,regulation of transcription from RNA polymerase II promoter involved in metanephros development (GO:0072212),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,ROBO2
141,GO_Biological_Process_2017b,axon guidance (GO:0007411),3/182,0.0018460376815523,0.0939129031841749,0,0,13.822625698324025,87.00947177574088,ROBO2;LRFN2;GFRA2
142,GO_Biological_Process_2017b,negative regulation of synapse assembly (GO:0051964),1/6,0.0080736268908127,0.0939129031841749,0,0,153.6,740.2218192098322,ROBO2
143,GO_Biological_Process_2017b,minus-end specific microtubule depolymerization (GO:0036078),1/9,0.0120868859385031,0.0939129031841749,0,0,95.98557692307692,423.8371981703313,STMN4
144,GO_Biological_Process_2017b,serotonergic neuron axon guidance (GO:0036515),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
145,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the internal capsule (GO:0021968),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
146,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the cerebral peduncle (GO:0021969),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
147,GO_Biological_Process_2017b,sensory neuron axon guidance (GO:0097374),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
148,GO_Biological_Process_2017b,interneuron axon guidance (GO:0097376),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
149,GO_Biological_Process_2017b,anterior/posterior axon guidance (GO:0033564),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
150,GO_Biological_Process_2017b,corticospinal neuron axon guidance through spinal cord (GO:0021972),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
151,GO_Biological_Process_2017b,sympathetic neuron axon guidance (GO:0097492),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
152,GO_Biological_Process_2017b,olfactory bulb axon guidance (GO:0071678),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
153,GO_Biological_Process_2017b,photoreceptor cell axon guidance (GO:0072499),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
154,GO_Biological_Process_2017b,dopaminergic neuron axon guidance (GO:0036514),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
155,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the medullary pyramid (GO:0021971),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
158,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the basilar pons (GO:0021970),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
178,GO_Biological_Process_2017b,metanephric juxtaglomerular apparatus development (GO:0072206),1/11,0.014753702756032,0.0939129031841749,0,0,76.78076923076924,323.7277777065472,ROBO2
159,GO_Biological_Process_2017b,dorsal/ventral axon guidance (GO:0033563),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
161,GO_Biological_Process_2017b,modulation by symbiont of host small GTPase mediated signal transduction (GO:0044082),2/129,0.0130399243931604,0.0939129031841749,0,0,12.501417322834646,54.252894819055925,TRIO;RHOJ
215,GO_Biological_Process_2017b,alditol phosphate metabolic process (GO:0052646),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
175,GO_Biological_Process_2017b,chemorepulsion of axon (GO:0061643),2/134,0.014016434660709,0.0939129031841749,0,0,12.024848484848484,51.31633832589081,ROBO2;GFRA2
174,GO_Biological_Process_2017b,regulation of Ras protein signal transduction (GO:0046578),2/134,0.014016434660709,0.0939129031841749,0,0,12.024848484848484,51.31633832589081,TRIO;RHOJ
173,GO_Biological_Process_2017b,motor neuron axon guidance (GO:0008045),2/133,0.0138186460808769,0.0939129031841749,0,0,12.117251908396948,51.88287897057053,ROBO2;GFRA2
172,GO_Biological_Process_2017b,negative regulation of small GTPase mediated signal transduction (GO:0051058),2/132,0.0136220973098662,0.0939129031841749,0,0,12.211076923076924,52.45954358014316,TRIO;RHOJ
171,GO_Biological_Process_2017b,mitotic spindle microtubule depolymerization (GO:1990755),1/10,0.0134211618656948,0.0939129031841749,0,0,85.31623931623932,367.7917019980768,STMN4
170,GO_Biological_Process_2017b,axonemal microtubule depolymerization (GO:0060404),1/10,0.0134211618656948,0.0939129031841749,0,0,85.31623931623932,367.7917019980768,STMN4
169,GO_Biological_Process_2017b,microtubule depolymerization (GO:0007019),1/10,0.0134211618656948,0.0939129031841749,0,0,85.31623931623932,367.7917019980768,STMN4
168,GO_Biological_Process_2017b,plus-end specific microtubule depolymerization (GO:0070462),1/10,0.0134211618656948,0.0939129031841749,0,0,85.31623931623932,367.7917019980768,STMN4
167,GO_Biological_Process_2017b,retinal ganglion cell axon guidance (GO:0031290),2/130,0.013232733004323,0.0939129031841749,0,0,12.403125,53.64428146710025,ROBO2;GFRA2
166,GO_Biological_Process_2017b,regulation of small GTPase mediated signal transduction (GO:0051056),2/130,0.013232733004323,0.0939129031841749,0,0,12.403125,53.64428146710025,TRIO;RHOJ
165,GO_Biological_Process_2017b,commissural neuron axon guidance (GO:0071679),2/130,0.013232733004323,0.0939129031841749,0,0,12.403125,53.64428146710025,ROBO2;GFRA2
164,GO_Biological_Process_2017b,Roundabout signaling pathway involved in axon guidance (GO:2001266),2/130,0.013232733004323,0.0939129031841749,0,0,12.403125,53.64428146710025,ROBO2;GFRA2
163,GO_Biological_Process_2017b,corticospinal neuron axon guidance (GO:0021966),2/129,0.0130399243931604,0.0939129031841749,0,0,12.501417322834646,54.252894819055925,ROBO2;GFRA2
162,GO_Biological_Process_2017b,VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378),2/129,0.0130399243931604,0.0939129031841749,0,0,12.501417322834646,54.252894819055925,ROBO2;GFRA2
160,GO_Biological_Process_2017b,corticospinal neuron axon guidance through the cerebral cortex (GO:0021967),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
216,GO_Biological_Process_2017b,D-glycero-D-manno-heptose 7-phosphate metabolic process (GO:2001060),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
219,GO_Biological_Process_2017b,phosphagen metabolic process (GO:0006599),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
218,GO_Biological_Process_2017b,"cyclic 2,3-bisphospho-D-glycerate biosynthetic process (GO:1901369)",1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
217,GO_Biological_Process_2017b,presynaptic membrane assembly (GO:0097105),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
228,GO_Biological_Process_2017b,molybdopterin cofactor metabolic process (GO:0043545),1/17,0.0227126314766075,0.0939129031841749,0,0,47.97355769230769,181.5719549673859,PTPRD
227,GO_Biological_Process_2017b,negative regulation of cornification (GO:1905716),1/17,0.0227126314766075,0.0939129031841749,0,0,47.97355769230769,181.5719549673859,MECOM
226,GO_Biological_Process_2017b,lipid X metabolic process (GO:2001289),1/17,0.0227126314766075,0.0939129031841749,0,0,47.97355769230769,181.5719549673859,PTPRD
225,GO_Biological_Process_2017b,metanephric part of ureteric bud development (GO:0035502),1/17,0.0227126314766075,0.0939129031841749,0,0,47.97355769230769,181.5719549673859,ROBO2
157,GO_Biological_Process_2017b,axon choice point recognition (GO:0016198),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
223,GO_Biological_Process_2017b,metanephric epithelium development (GO:0072207),1/17,0.0227126314766075,0.0939129031841749,0,0,47.97355769230769,181.5719549673859,ROBO2
224,GO_Biological_Process_2017b,thiamine diphosphate metabolic process (GO:0042357),1/17,0.0227126314766075,0.0939129031841749,0,0,47.97355769230769,181.5719549673859,PTPRD
220,GO_Biological_Process_2017b,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
156,GO_Biological_Process_2017b,semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),2/128,0.012848369431055,0.0939129031841749,0,0,12.601269841269842,54.87271301206963,ROBO2;GFRA2
222,GO_Biological_Process_2017b,L-methionine biosynthetic process from O-phospho-L-homoserine and cystathionine (GO:0019283),1/17,0.0227126314766075,0.0939129031841749,0,0,47.97355769230769,181.5719549673859,PTPRD
221,GO_Biological_Process_2017b,glucose 1-phosphate metabolic process (GO:0019255),1/16,0.0213904560937906,0.0939129031841749,0,0,51.174358974358974,196.7557093049865,PTPRD
229,GO_Biological_Process_2017b,metanephric mesenchyme development (GO:0072075),1/18,0.0240330867565966,0.0961323470263864,0,0,45.14932126696833,168.33128827465845,ROBO2
230,GO_Biological_Process_2017b,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1/18,0.0240330867565966,0.0961323470263864,0,0,45.14932126696833,168.33128827465845,PTPRD
231,GO_Biological_Process_2017b,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1/18,0.0240330867565966,0.0961323470263864,0,0,45.14932126696833,168.33128827465845,PTPRD
232,GO_Biological_Process_2017b,pyridoxal phosphate metabolic process (GO:0042822),1/19,0.0253518240632961,0.0961801160339481,0,0,42.638888888888886,156.69384876205734,PTPRD
233,GO_Biological_Process_2017b,positive regulation of protein targeting to vacuolar membrane (GO:1900485),1/19,0.0253518240632961,0.0961801160339481,0,0,42.638888888888886,156.69384876205734,TCAF1
235,GO_Biological_Process_2017b,regulation of intermediate filament polymerization or depolymerization (GO:0045108),1/19,0.0253518240632961,0.0961801160339481,0,0,42.638888888888886,156.69384876205734,STMN4
236,GO_Biological_Process_2017b,negative regulation of cytoskeleton organization (GO:0051494),1/19,0.0253518240632961,0.0961801160339481,0,0,42.638888888888886,156.69384876205734,STMN4
234,GO_Biological_Process_2017b,GDP-mannose biosynthetic process from fructose-6-phosphate (GO:0061729),1/19,0.0253518240632961,0.0961801160339481,0,0,42.638888888888886,156.69384876205734,PTPRD
237,GO_Biological_Process_2017b,negative regulation of plant-type hypersensitive response (GO:0034051),1/20,0.0266688455361458,0.0981413515730166,0,0,40.392712550607285,146.39366123411943,MECOM
238,GO_Biological_Process_2017b,glucose 6-phosphate metabolic process (GO:0051156),1/20,0.0266688455361458,0.0981413515730166,0,0,40.392712550607285,146.39366123411943,PTPRD
239,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091),1/20,0.0266688455361458,0.0981413515730166,0,0,40.392712550607285,146.39366123411943,CHD6
240,GO_Biological_Process_2017b,regulation of cytoskeleton organization (GO:0051493),1/21,0.0279841533165139,0.0999822176745354,0,0,38.371153846153845,137.21973105106596,STMN4
241,GO_Biological_Process_2017b,sprouting angiogenesis (GO:0002040),1/21,0.0279841533165139,0.0999822176745354,0,0,38.371153846153845,137.21973105106596,RNF213
242,GO_Biological_Process_2017b,tyrosine catabolic process to phosphoenolpyruvate (GO:0019446),1/21,0.0279841533165139,0.0999822176745354,0,0,38.371153846153845,137.21973105106596,PTPRD
244,GO_Biological_Process_2017b,negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299),1/22,0.0292977495261991,0.1017129417513327,0,0,36.54212454212454,129.00263688319484,MECOM
245,GO_Biological_Process_2017b,fructose 6-phosphate metabolic process (GO:0006002),1/22,0.0292977495261991,0.1017129417513327,0,0,36.54212454212454,129.00263688319484,PTPRD
243,GO_Biological_Process_2017b,endothelial stalk cell fate specification (GO:0097103),1/22,0.0292977495261991,0.1017129417513327,0,0,36.54212454212454,129.00263688319484,RNF213
246,GO_Biological_Process_2017b,glycerol to glycerone phosphate metabolic process (GO:0061610),1/23,0.0306096363049701,0.103342625323202,0,0,34.87937062937063,121.60484715637172,PTPRD
247,GO_Biological_Process_2017b,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/23,0.0306096363049701,0.103342625323202,0,0,34.87937062937063,121.60484715637172,PTPRD
248,GO_Biological_Process_2017b,endothelial tip cell fate specification (GO:0097102),1/23,0.0306096363049701,0.103342625323202,0,0,34.87937062937063,121.60484715637172,RNF213
249,GO_Biological_Process_2017b,neurexin clustering involved in presynaptic membrane assembly (GO:0097115),1/25,0.0332282900970065,0.1093358709286196,0,0,31.96955128205128,108.83565874121032,PTPRD
250,GO_Biological_Process_2017b,positive regulation of cytoskeleton organization (GO:0051495),1/25,0.0332282900970065,0.1093358709286196,0,0,31.96955128205128,108.83565874121032,STMN4
251,GO_Biological_Process_2017b,planar cell polarity pathway involved in axon guidance (GO:1904938),2/213,0.0332761346304494,0.1093358709286196,0,0,7.492701421800948,25.497024685327847,ROBO2;GFRA2
23,GO_Biological_Process_2018,positive regulation of dendrite morphogenesis (GO:0050775),1/16,0.0213904560937906,0.1126895946339373,0,0,51.174358974358974,196.7557093049865,PTPRD
22,GO_Biological_Process_2018,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,0.0213904560937906,0.1126895946339373,0,0,51.174358974358974,196.7557093049865,RHOJ
21,GO_Biological_Process_2018,presynapse assembly (GO:0099054),1/15,0.020066558464378,0.1126895946339373,0,0,54.832417582417584,214.3235039145759,PTPRD
18,GO_Biological_Process_2018,regulation of histone modification (GO:0031056),1/14,0.0187409364492418,0.1126895946339373,0,0,59.05325443786983,234.8574522333829,PRDM10
24,GO_Biological_Process_2018,mesonephric tubule development (GO:0072164),1/17,0.0227126314766075,0.1126895946339373,0,0,47.97355769230769,181.5719549673859,ROBO2
19,GO_Biological_Process_2018,axon guidance (GO:0007411),2/158,0.0191264443639075,0.1126895946339373,0,0,10.162564102564104,40.21004848102547,ROBO2;GFRA2
17,GO_Biological_Process_2018,regulation of histone methylation (GO:0031060),1/12,0.0160845107297618,0.1126895946339373,0,0,69.7972027972028,288.2553656873905,PRDM10
16,GO_Biological_Process_2018,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/142,0.0156429645074838,0.1126895946339373,0,0,11.333142857142857,47.12019355753685,PTPRD;ROBO2
20,GO_Biological_Process_2018,microtubule depolymerization (GO:0007019),1/15,0.020066558464378,0.1126895946339373,0,0,54.832417582417584,214.3235039145759,STMN4
25,GO_Biological_Process_2018,ureteric bud development (GO:0001657),1/17,0.0227126314766075,0.1126895946339373,0,0,47.97355769230769,181.5719549673859,ROBO2
7,GO_Biological_Process_2018,retinal ganglion cell axon guidance (GO:0031290),1/6,0.0080736268908127,0.1126895946339373,0,0,153.6,740.2218192098322,ROBO2
12,GO_Biological_Process_2018,presynaptic membrane organization (GO:0097090),1/11,0.014753702756032,0.1126895946339373,0,0,76.78076923076924,323.7277777065472,PTPRD
5,GO_Biological_Process_2018,regulation of cytoskeleton organization (GO:0051493),2/95,0.0072534505141677,0.1126895946339373,0,0,17.101075268817205,84.2446507080431,RHOJ;STMN4
6,GO_Biological_Process_2018,regulation of anion channel activity (GO:0010359),1/6,0.0080736268908127,0.1126895946339373,0,0,153.6,740.2218192098322,TCAF1
15,GO_Biological_Process_2018,regulation of small GTPase mediated signal transduction (GO:0051056),2/140,0.0152290097279971,0.1126895946339373,0,0,11.49855072463768,48.11629648655324,TRIO;RHOJ
8,GO_Biological_Process_2018,negative regulation of synapse organization (GO:1905809),1/7,0.0094131205361766,0.1126895946339373,0,0,127.99358974358974,597.1733894173036,ROBO2
9,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,0.0107508728609495,0.1126895946339373,0,0,109.7032967032967,497.25962914000377,CHD6
10,GO_Biological_Process_2018,Cdc42 protein signal transduction (GO:0032488),1/9,0.0120868859385031,0.1126895946339373,0,0,95.98557692307692,423.8371981703313,RHOJ
11,GO_Biological_Process_2018,presynaptic membrane assembly (GO:0097105),1/10,0.0134211618656948,0.1126895946339373,0,0,85.31623931623932,367.7917019980768,PTPRD
14,GO_Biological_Process_2018,negative regulation of chemotaxis (GO:0050922),1/11,0.014753702756032,0.1126895946339373,0,0,76.78076923076924,323.7277777065472,ROBO2
13,GO_Biological_Process_2018,regulation of non-canonical Wnt signaling pathway (GO:2000050),1/11,0.014753702756032,0.1126895946339373,0,0,76.78076923076924,323.7277777065472,RNF213
33,GO_Biological_Process_2018,membrane assembly (GO:0071709),1/23,0.0306096363049701,0.1128183738097471,0,0,34.87937062937063,121.60484715637172,PTPRD
34,GO_Biological_Process_2018,microtubule polymerization or depolymerization (GO:0031109),1/23,0.0306096363049701,0.1128183738097471,0,0,34.87937062937063,121.60484715637172,STMN4
26,GO_Biological_Process_2018,cell projection assembly (GO:0030031),1/20,0.0266688455361458,0.1128183738097471,0,0,40.392712550607285,146.39366123411943,RHOJ
27,GO_Biological_Process_2018,covalent chromatin modification (GO:0016569),1/20,0.0266688455361458,0.1128183738097471,0,0,40.392712550607285,146.39366123411943,PRDM10
28,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.0279841533165139,0.1128183738097471,0,0,38.371153846153845,137.21973105106596,CHD6
29,GO_Biological_Process_2018,negative regulation of nervous system development (GO:0051961),1/22,0.0292977495261991,0.1128183738097471,0,0,36.54212454212454,129.00263688319484,ROBO2
30,GO_Biological_Process_2018,positive regulation of protein targeting to membrane (GO:0090314),1/22,0.0292977495261991,0.1128183738097471,0,0,36.54212454212454,129.00263688319484,TCAF1
31,GO_Biological_Process_2018,metanephros development (GO:0001656),1/23,0.0306096363049701,0.1128183738097471,0,0,34.87937062937063,121.60484715637172,ROBO2
32,GO_Biological_Process_2018,positive regulation of ion transmembrane transporter activity (GO:0032414),1/23,0.0306096363049701,0.1128183738097471,0,0,34.87937062937063,121.60484715637172,TCAF1
38,GO_Biological_Process_2018,regulation of protein targeting to membrane (GO:0090313),1/27,0.0358401317118484,0.1139361209601966,0,0,29.507396449704142,98.22088743474232,TCAF1
36,GO_Biological_Process_2018,protein depolymerization (GO:0051261),1/25,0.0332282900970065,0.1139361209601966,0,0,31.96955128205128,108.83565874121032,STMN4
37,GO_Biological_Process_2018,positive regulation of synapse assembly (GO:0051965),1/26,0.0345350613606546,0.1139361209601966,0,0,30.689230769230768,103.29320526635196,PTPRD
39,GO_Biological_Process_2018,positive regulation of sprouting angiogenesis (GO:1903672),1/28,0.0371435032676452,0.1139361209601966,0,0,28.413105413105413,93.56340148780022,RHOJ
40,GO_Biological_Process_2018,negative regulation of JNK cascade (GO:0046329),1/28,0.0371435032676452,0.1139361209601966,0,0,28.413105413105413,93.56340148780022,MECOM
42,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/29,0.0384451781473962,0.1139361209601966,0,0,27.396978021978025,89.27365552728025,CHD6
43,GO_Biological_Process_2018,negative regulation of stress-activated MAPK cascade (GO:0032873),1/30,0.0397451584744871,0.1139361209601966,0,0,26.450928381962864,85.31131290182489,MECOM
44,GO_Biological_Process_2018,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/30,0.0397451584744871,0.1139361209601966,0,0,26.450928381962864,85.31131290182489,RHOJ
35,GO_Biological_Process_2018,macromolecule modification (GO:0043412),1/24,0.0319198157870248,0.1139361209601966,0,0,33.36120401337793,114.91361059553886,PRDM10
41,GO_Biological_Process_2018,cortical cytoskeleton organization (GO:0030865),1/29,0.0384451781473962,0.1139361209601966,0,0,27.396978021978025,89.27365552728025,RHOJ
252,GO_Biological_Process_2017b,negative regulation of necroptotic process (GO:0060546),1/27,0.0358401317118484,0.1156944602628089,0,0,29.507396449704142,98.22088743474232,MECOM
253,GO_Biological_Process_2017b,blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/27,0.0358401317118484,0.1156944602628089,0,0,29.507396449704142,98.22088743474232,RNF213
46,GO_Biological_Process_2018,negative regulation of fat cell differentiation (GO:0045599),1/32,0.0423400439315086,0.1162099078120131,0,0,24.741935483870968,78.2345437210345,TRIO
45,GO_Biological_Process_2018,positive regulation of dendrite development (GO:1900006),1/32,0.0423400439315086,0.1162099078120131,0,0,24.741935483870968,78.2345437210345,PTPRD
254,GO_Biological_Process_2017b,positive regulation of dendrite morphogenesis (GO:0050775),1/29,0.0384451781473962,0.1230245700716679,0,0,27.396978021978025,89.27365552728025,PTPRD
256,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to reactive oxygen species (GO:1990095),1/30,0.0397451584744871,0.1239510027000956,0,0,26.450928381962864,85.31131290182489,CHD6
255,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to hydrogen peroxide (GO:0061407),1/30,0.0397451584744871,0.1239510027000956,0,0,26.450928381962864,85.31131290182489,CHD6
257,GO_Biological_Process_2017b,phenylalanine catabolic process to phosphoenolpyruvate (GO:0019562),1/30,0.0397451584744871,0.1239510027000956,0,0,26.450928381962864,85.31131290182489,PTPRD
260,GO_Biological_Process_2017b,cellular response to ethylene stimulus (GO:0071369),1/33,0.0436349532899167,0.1305501041519461,0,0,23.96754807692308,75.0638863791398,ROBO2
262,GO_Biological_Process_2017b,cellular response to cytokinin stimulus (GO:0071368),1/33,0.0436349532899167,0.1305501041519461,0,0,23.96754807692308,75.0638863791398,ROBO2
258,GO_Biological_Process_2017b,cellular response to gibberellin stimulus (GO:0071370),1/33,0.0436349532899167,0.1305501041519461,0,0,23.96754807692308,75.0638863791398,ROBO2
259,GO_Biological_Process_2017b,cellular response to abscisic acid stimulus (GO:0071215),1/33,0.0436349532899167,0.1305501041519461,0,0,23.96754807692308,75.0638863791398,ROBO2
261,GO_Biological_Process_2017b,cellular response to auxin stimulus (GO:0071365),1/33,0.0436349532899167,0.1305501041519461,0,0,23.96754807692308,75.0638863791398,ROBO2
47,GO_Biological_Process_2018,positive regulation of axonogenesis (GO:0050772),1/37,0.0487977508038484,0.1311439552853428,0,0,21.30021367521368,64.32815883418561,ROBO2
48,GO_Biological_Process_2018,homotypic cell-cell adhesion (GO:0034109),1/38,0.0500842507282723,0.1318544559989211,0,0,20.72349272349272,62.04714597227348,MEGF11
263,GO_Biological_Process_2017b,positive regulation of dendritic spine morphogenesis (GO:0061003),1/35,0.046219715818065,0.1371681888794187,0,0,22.555429864253394,69.34325924679375,PTPRD
264,GO_Biological_Process_2017b,platelet aggregation (GO:0070527),1/36,0.0475095732087328,0.1376655349670369,0,0,21.90989010989011,66.75558005419848,MEGF11
265,GO_Biological_Process_2017b,cellular response to parathyroid hormone stimulus (GO:0071374),1/36,0.0475095732087328,0.1376655349670369,0,0,21.90989010989011,66.75558005419848,ROBO2
266,GO_Biological_Process_2017b,positive regulation of axon guidance (GO:1902669),1/36,0.0475095732087328,0.1376655349670369,0,0,21.90989010989011,66.75558005419848,ROBO2
267,GO_Biological_Process_2017b,negative regulation of non-canonical Wnt signaling pathway (GO:2000051),1/37,0.0487977508038484,0.1381351715062788,0,0,21.30021367521368,64.32815883418561,RNF213
268,GO_Biological_Process_2017b,cellular response to jasmonic acid stimulus (GO:0071395),1/37,0.0487977508038484,0.1381351715062788,0,0,21.30021367521368,64.32815883418561,ROBO2
269,GO_Biological_Process_2017b,negative regulation of JNK cascade (GO:0046329),1/37,0.0487977508038484,0.1381351715062788,0,0,21.30021367521368,64.32815883418561,MECOM
270,GO_Biological_Process_2017b,cellular response to gonadotropin stimulus (GO:0071371),1/38,0.0500842507282723,0.1396288202121532,0,0,20.72349272349272,62.04714597227348,ROBO2
271,GO_Biological_Process_2017b,cell migration involved in sprouting angiogenesis (GO:0002042),1/38,0.0500842507282723,0.1396288202121532,0,0,20.72349272349272,62.04714597227348,RNF213
135,WikiPathways_2019_Human,Regulation of Microtubule Cytoskeleton WP2038,1/46,0.0603161049564981,0.1407375782318289,0,0,17.032478632478632,47.829859287186046,TRIO
134,WikiPathways_2019_Human,Development and heterogeneity of the ILC family WP3893,1/32,0.0423400439315086,0.1407375782318289,0,0,24.741935483870968,78.2345437210345,TOX
133,WikiPathways_2019_Human,White fat cell differentiation WP4149,1/32,0.0423400439315086,0.1407375782318289,0,0,24.741935483870968,78.2345437210345,MECOM
272,GO_Biological_Process_2017b,regulation of microtubule cytoskeleton organization (GO:0070507),1/39,0.0513690750681718,0.1421339821435129,0,0,20.17712550607288,59.9002146437606,STMN4
49,GO_Biological_Process_2018,regulation of ion transmembrane transporter activity (GO:0032412),1/42,0.0552135155533288,0.1424508701275885,0,0,18.69793621013133,54.15946054707467,TCAF1
274,GO_Biological_Process_2017b,cytoplasmic microtubule depolymerization (GO:0010938),1/40,0.0526522259283912,0.1424707289827057,0,0,19.65877712031558,57.87635915452169,STMN4
275,GO_Biological_Process_2017b,cellular response to hormone stimulus (GO:0032870),1/40,0.0526522259283912,0.1424707289827057,0,0,19.65877712031558,57.87635915452169,ROBO2
273,GO_Biological_Process_2017b,cellular response to leptin stimulus (GO:0044320),1/40,0.0526522259283912,0.1424707289827057,0,0,19.65877712031558,57.87635915452169,ROBO2
51,GO_Biological_Process_2018,regulation of dendrite morphogenesis (GO:0048814),1/44,0.0577681363361376,0.1433094151415721,0,0,17.826475849731665,50.82895021500038,PTPRD
50,GO_Biological_Process_2018,sprouting angiogenesis (GO:0002040),1/44,0.0577681363361376,0.1433094151415721,0,0,17.826475849731665,50.82895021500038,RNF213
52,GO_Biological_Process_2018,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/45,0.059042951121717,0.1437083149943678,0,0,17.420454545454547,49.29100393195118,RHOJ
276,GO_Biological_Process_2017b,positive regulation of protein targeting to membrane (GO:0090314),1/41,0.0539337053893905,0.144873018856173,0,0,19.166346153846156,55.96572434095457,TCAF1
53,GO_Biological_Process_2018,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.061587599908768,0.1471259331153903,0,0,16.661371237458194,46.440152226223375,PTPRD
277,GO_Biological_Process_2017b,cellular response to prostaglandin stimulus (GO:0071379),1/42,0.0552135155533288,0.1472360414755437,0,0,18.69793621013133,54.15946054707467,ROBO2
278,GO_Biological_Process_2017b,sucrose catabolic process via 3'-ketosucrose (GO:0019574),1/43,0.0564916585091406,0.1495606498659262,0,0,18.251831501831504,52.44959988716816,PTPRD
54,GO_Biological_Process_2018,protein autoubiquitination (GO:0051865),1/49,0.0641256214892022,0.150403730401947,0,0,15.965544871794872,43.85593535873217,RNF213
279,GO_Biological_Process_2017b,cellular response to thyroid hormone stimulus (GO:0097067),1/44,0.0577681363361376,0.1507707388063733,0,0,17.826475849731665,50.82895021500038,ROBO2
280,GO_Biological_Process_2017b,dephosphorylation (GO:0016311),1/44,0.0577681363361376,0.1507707388063733,0,0,17.826475849731665,50.82895021500038,PTPRD
281,GO_Biological_Process_2017b,cellular response to brassinosteroid stimulus (GO:0071367),1/45,0.059042951121717,0.1530127183999427,0,0,17.420454545454547,49.29100393195118,ROBO2
282,GO_Biological_Process_2017b,phosphorylation (GO:0016310),1/46,0.0603161049564981,0.1552190673006385,0,0,17.032478632478632,47.829859287186046,PTPRD
283,GO_Biological_Process_2017b,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.061587599908768,0.1563050811477699,0,0,16.661371237458194,46.440152226223375,PTPRD
284,GO_Biological_Process_2017b,negative regulation of programmed cell death (GO:0043069),1/47,0.061587599908768,0.1563050811477699,0,0,16.661371237458194,46.440152226223375,MECOM
55,GO_Biological_Process_2018,positive regulation of nervous system development (GO:0051962),1/52,0.067920264117738,0.1564591798426465,0,0,15.024132730015085,40.40621579213957,PTPRD
285,GO_Biological_Process_2017b,cellular response to peptide hormone stimulus (GO:0071375),1/48,0.0628574380669868,0.1584351863606244,0,0,16.306055646481177,45.11699715873728,ROBO2
56,GO_Biological_Process_2018,regulation of axonogenesis (GO:0050770),1/55,0.0717000886591322,0.1622686217022466,0,0,14.187321937321938,37.38732875362038,ROBO2
286,GO_Biological_Process_2017b,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/52,0.067920264117738,0.170031681600868,0,0,15.024132730015085,40.40621579213957,ROBO2
287,GO_Biological_Process_2017b,metanephros development (GO:0001656),1/53,0.0691818493313732,0.1720197334726037,0,0,14.7344674556213,39.35600928291532,ROBO2
318,GO_Biological_Process_2017b,hair cell differentiation (GO:0035315),1/72,0.0928418711410691,0.1750849590626063,0,0,10.781148429035753,25.62525396907896,PTPRD
319,GO_Biological_Process_2017b,sevenless signaling pathway (GO:0045500),1/72,0.0928418711410691,0.1750849590626063,0,0,10.781148429035753,25.62525396907896,GFRA2
324,GO_Biological_Process_2017b,brain-derived neurotrophic factor receptor signaling pathway (GO:0031547),1/75,0.0965243203976375,0.1750849590626063,0,0,10.342515592515593,24.18039062518233,GFRA2
321,GO_Biological_Process_2017b,Tie signaling pathway (GO:0048014),1/74,0.0952984396193821,0.1750849590626063,0,0,10.484720758693362,24.64687178715262,GFRA2
336,GO_Biological_Process_2017b,negative regulation of hematopoietic stem cell migration (GO:2000472),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
335,GO_Biological_Process_2017b,peripheral nervous system neuron differentiation (GO:0048934),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,PTPRD
334,GO_Biological_Process_2017b,neuromast deposition (GO:0048885),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
339,GO_Biological_Process_2017b,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,GFRA2
332,GO_Biological_Process_2017b,negative regulation of mesenchymal stem cell migration (GO:1905321),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
331,GO_Biological_Process_2017b,negative regulation of distal tip cell migration (GO:1903355),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
320,GO_Biological_Process_2017b,retrograde extension (GO:0003389),1/72,0.0928418711410691,0.1750849590626063,0,0,10.781148429035753,25.62525396907896,STMN4
330,GO_Biological_Process_2017b,neuron projection regeneration (GO:0031102),1/76,0.0977486015575413,0.1750849590626063,0,0,10.204102564102564,23.72817506630132,STMN4
328,GO_Biological_Process_2017b,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),1/76,0.0977486015575413,0.1750849590626063,0,0,10.204102564102564,23.72817506630132,GFRA2
327,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),1/76,0.0977486015575413,0.1750849590626063,0,0,10.204102564102564,23.72817506630132,GFRA2
326,GO_Biological_Process_2017b,axon extension (GO:0048675),1/75,0.0965243203976375,0.1750849590626063,0,0,10.342515592515593,24.18039062518233,LRFN2
325,GO_Biological_Process_2017b,inner ear receptor stereocilium organization (GO:0060122),1/75,0.0965243203976375,0.1750849590626063,0,0,10.342515592515593,24.18039062518233,STMN4
323,GO_Biological_Process_2017b,axon development (GO:0061564),1/75,0.0965243203976375,0.1750849590626063,0,0,10.342515592515593,24.18039062518233,STMN4
322,GO_Biological_Process_2017b,glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),1/74,0.0952984396193821,0.1750849590626063,0,0,10.484720758693362,24.64687178715262,GFRA2
329,GO_Biological_Process_2017b,cellular process regulating host cell cycle in response to virus (GO:0060154),1/76,0.0977486015575413,0.1750849590626063,0,0,10.204102564102564,23.72817506630132,MECOM
317,GO_Biological_Process_2017b,neuron projection fasciculation (GO:0106030),1/72,0.0928418711410691,0.1750849590626063,0,0,10.781148429035753,25.62525396907896,STMN4
313,GO_Biological_Process_2017b,neuron fate commitment (GO:0048663),1/68,0.0879094500534163,0.1750849590626063,0,0,11.427095292766934,27.78438766321713,PTPRD
314,GO_Biological_Process_2017b,amacrine cell differentiation (GO:0035881),1/68,0.0879094500534163,0.1750849590626063,0,0,11.427095292766934,27.78438766321713,PTPRD
312,GO_Biological_Process_2017b,regulation of cell cycle process (GO:0010564),1/68,0.0879094500534163,0.1750849590626063,0,0,11.427095292766934,27.78438766321713,MECOM
311,GO_Biological_Process_2017b,noradrenergic neuron differentiation (GO:0003357),1/67,0.0866723154837573,0.1750849590626063,0,0,11.60081585081585,28.37119607885258,PTPRD
310,GO_Biological_Process_2017b,cardiac neuron differentiation (GO:0060945),1/66,0.0854335651408865,0.1750849590626063,0,0,11.779881656804733,28.978699956832514,PTPRD
309,GO_Biological_Process_2017b,central nervous system neuron axonogenesis (GO:0021955),1/65,0.0841931969958912,0.1750849590626063,0,0,11.96454326923077,29.607951196009186,LRFN2
308,GO_Biological_Process_2017b,GABAergic neuron differentiation (GO:0097154),1/64,0.08295120902835,0.1750849590626063,0,0,12.155067155067156,30.260072343994267,PTPRD
307,GO_Biological_Process_2017b,regulation of cell cycle checkpoint (GO:1901976),1/64,0.08295120902835,0.1750849590626063,0,0,12.155067155067156,30.260072343994267,MECOM
306,GO_Biological_Process_2017b,regulation of meiotic cell cycle (GO:0051445),1/64,0.08295120902835,0.1750849590626063,0,0,12.155067155067156,30.260072343994267,MECOM
305,GO_Biological_Process_2017b,Rohon-Beard neuron differentiation (GO:1905275),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,PTPRD
304,GO_Biological_Process_2017b,neuron differentiation involved in salivary gland development (GO:0060705),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,PTPRD
303,GO_Biological_Process_2017b,peripheral nervous system neuron axonogenesis (GO:0048936),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,LRFN2
302,GO_Biological_Process_2017b,neuron differentiation involved in amphid sensory organ development (GO:0003387),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,PTPRD
301,GO_Biological_Process_2017b,glutamatergic neuron differentiation (GO:1905962),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,PTPRD
300,GO_Biological_Process_2017b,medial motor column neuron differentiation (GO:0021526),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,PTPRD
299,GO_Biological_Process_2017b,modulation by symbiont of host cell cycle (GO:0044071),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,MECOM
298,GO_Biological_Process_2017b,retinal bipolar neuron differentiation (GO:0060040),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,PTPRD
297,GO_Biological_Process_2017b,regulation of cell cycle (GO:0051726),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,MECOM
296,GO_Biological_Process_2017b,photoreceptor cell differentiation (GO:0046530),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,PTPRD
295,GO_Biological_Process_2017b,mechanoreceptor differentiation (GO:0042490),1/63,0.0817075991872228,0.1750849590626063,0,0,12.351736972704714,30.936262547654483,PTPRD
294,GO_Biological_Process_2017b,cellular response to steroid hormone stimulus (GO:0071383),1/61,0.0792155057834973,0.1750849590626063,0,0,12.76474358974359,32.366069643921364,ROBO2
293,GO_Biological_Process_2017b,collateral sprouting (GO:0048668),1/59,0.076716900477825,0.1750849590626063,0,0,13.206233421750664,33.90876403657074,LRFN2
315,GO_Biological_Process_2017b,neuron differentiation (GO:0030182),1/70,0.0903788799946025,0.1750849590626063,0,0,11.094760312151616,26.668970934836352,PTPRD
291,GO_Biological_Process_2017b,axon arborization (GO:0140060),1/58,0.0754651507447108,0.1750849590626063,0,0,13.43859649122807,34.726466325654,LRFN2
290,GO_Biological_Process_2017b,negative regulation of JUN kinase activity (GO:0043508),1/57,0.0742117668943126,0.1750849590626063,0,0,13.67925824175824,35.577460203094,MECOM
289,GO_Biological_Process_2017b,inositol phosphate metabolic process (GO:0043647),1/57,0.0742117668943126,0.1750849590626063,0,0,13.67925824175824,35.577460203094,PTPRD
288,GO_Biological_Process_2017b,regulation of actin cytoskeleton organization (GO:0032956),1/56,0.0729567468907788,0.1750849590626063,0,0,13.928671328671328,36.46370879499823,STMN4
316,GO_Biological_Process_2017b,positive regulation of axonogenesis (GO:0050772),1/71,0.0916111794054683,0.1750849590626063,0,0,10.935714285714283,26.13856581636218,ROBO2
292,GO_Biological_Process_2017b,phospholipid metabolic process (GO:0006644),1/59,0.076716900477825,0.1750849590626063,0,0,13.206233421750664,33.90876403657074,PTPRD
333,GO_Biological_Process_2017b,negative regulation of neuroblast migration (GO:0061855),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
337,GO_Biological_Process_2017b,negative regulation of cell migration in other organism (GO:0044622),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
350,GO_Biological_Process_2017b,negative regulation of chemokine activity (GO:1900137),1/80,0.1026297699643217,0.1750849590626063,0,0,9.685491723466408,22.05025422007099,TCAF1
351,GO_Biological_Process_2017b,negative regulation of endothelial cell chemotaxis to vascular endothelial growth factor (GO:1904858),1/80,0.1026297699643217,0.1750849590626063,0,0,9.685491723466408,22.05025422007099,TCAF1
352,GO_Biological_Process_2017b,neurotrophin TRK receptor signaling pathway (GO:0048011),1/80,0.1026297699643217,0.1750849590626063,0,0,9.685491723466408,22.05025422007099,GFRA2
353,GO_Biological_Process_2017b,negative regulation of leukocyte migration (GO:0002686),1/81,0.1038460830238891,0.1750849590626063,0,0,9.563942307692308,21.66085119098212,TCAF1
354,GO_Biological_Process_2017b,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/82,0.1050608084632341,0.1750849590626063,0,0,9.44539411206078,21.282512839552783,MECOM
355,GO_Biological_Process_2017b,insulin-like growth factor receptor signaling pathway (GO:0048009),1/82,0.1050608084632341,0.1750849590626063,0,0,9.44539411206078,21.282512839552783,GFRA2
356,GO_Biological_Process_2017b,negative regulation of trophoblast cell migration (GO:1901164),1/82,0.1050608084632341,0.1750849590626063,0,0,9.44539411206078,21.282512839552783,TCAF1
357,GO_Biological_Process_2017b,positive regulation of collateral sprouting (GO:0048672),1/82,0.1050608084632341,0.1750849590626063,0,0,9.44539411206078,21.282512839552783,ROBO2
358,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.1062739482697551,0.1750849590626063,0,0,9.329737335834896,20.914799669740503,PTPRD
359,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.1062739482697551,0.1750849590626063,0,0,9.329737335834896,20.914799669740503,PTPRD
360,GO_Biological_Process_2017b,hepatocyte growth factor receptor signaling pathway (GO:0048012),1/83,0.1062739482697551,0.1750849590626063,0,0,9.329737335834896,20.914799669740503,GFRA2
361,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.1074855044212984,0.1750849590626063,0,0,9.216867469879515,20.55729459723843,PTPRD
362,GO_Biological_Process_2017b,negative regulation of fibroblast migration (GO:0010764),1/85,0.108695478928664,0.1750849590626063,0,0,9.106684981684982,20.20960155430532,TCAF1
340,GO_Biological_Process_2017b,ubiquitin-dependent protein catabolic process (GO:0006511),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,RNF213
364,GO_Biological_Process_2017b,brain segmentation (GO:0035284),1/85,0.108695478928664,0.1750849590626063,0,0,9.106684981684982,20.20960155430532,ROBO2
365,GO_Biological_Process_2017b,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/85,0.108695478928664,0.1750849590626063,0,0,9.106684981684982,20.20960155430532,GFRA2
366,GO_Biological_Process_2017b,trigeminal sensory nucleus development (GO:0021730),1/85,0.108695478928664,0.1750849590626063,0,0,9.106684981684982,20.20960155430532,ROBO2
367,GO_Biological_Process_2017b,"negative regulation of wound healing, spreading of epidermal cells (GO:1903690)",1/86,0.1099038737594078,0.1750849590626063,0,0,8.999095022624434,19.871344206358376,TCAF1
368,GO_Biological_Process_2017b,neuron development (GO:0048666),1/86,0.1099038737594078,0.1750849590626063,0,0,8.999095022624434,19.871344206358376,PTPRD
369,GO_Biological_Process_2017b,positive regulation of cell cycle (GO:0045787),1/86,0.1099038737594078,0.1750849590626063,0,0,8.999095022624434,19.871344206358376,MECOM
370,GO_Biological_Process_2017b,negative regulation of smooth muscle cell migration (GO:0014912),1/86,0.1099038737594078,0.1750849590626063,0,0,8.999095022624434,19.871344206358376,TCAF1
349,GO_Biological_Process_2017b,negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848),1/80,0.1026297699643217,0.1750849590626063,0,0,9.685491723466408,22.05025422007099,TCAF1
348,GO_Biological_Process_2017b,growth hormone receptor signaling pathway (GO:0060396),1/80,0.1026297699643217,0.1750849590626063,0,0,9.685491723466408,22.05025422007099,GFRA2
363,GO_Biological_Process_2017b,ubiquitin-dependent SMAD protein catabolic process (GO:0030579),1/85,0.108695478928664,0.1750849590626063,0,0,9.106684981684982,20.20960155430532,RNF213
346,GO_Biological_Process_2017b,negative regulation of muscle cell chemotaxis toward tendon cell (GO:2001282),1/79,0.1014118672915999,0.1750849590626063,0,0,9.810157790927022,22.451185336763995,TCAF1
347,GO_Biological_Process_2017b,regulation of multivesicular body size involved in ubiquitin-dependent protein catabolism (GO:0010798),1/79,0.1014118672915999,0.1750849590626063,0,0,9.810157790927022,22.451185336763995,RNF213
341,GO_Biological_Process_2017b,negative regulation of glial cell migration (GO:1903976),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
342,GO_Biological_Process_2017b,negative regulation of metanephric mesenchymal cell migration (GO:2000590),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
338,GO_Biological_Process_2017b,negative regulation of formation of radial glial scaffolds (GO:0061925),1/77,0.0989712850798696,0.1750849590626063,0,0,10.069331983805668,23.28961492092306,TCAF1
344,GO_Biological_Process_2017b,negative regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905311),1/78,0.1001923729898059,0.1750849590626063,0,0,9.93806193806194,22.864133490479528,TCAF1
343,GO_Biological_Process_2017b,dopaminergic neuron differentiation (GO:0071542),1/78,0.1001923729898059,0.1750849590626063,0,0,9.93806193806194,22.864133490479528,PTPRD
345,GO_Biological_Process_2017b,negative regulation of fibroblast chemotaxis (GO:1905211),1/79,0.1014118672915999,0.1750849590626063,0,0,9.810157790927022,22.451185336763995,TCAF1
372,GO_Biological_Process_2017b,ventricular system development (GO:0021591),1/87,0.1111106909148682,0.1754881298569593,0,0,8.894007155635062,19.54216474848468,ROBO2
371,GO_Biological_Process_2017b,"negative regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904236)",1/87,0.1111106909148682,0.1754881298569593,0,0,8.894007155635062,19.54216474848468,TCAF1
373,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.1123159323620213,0.1766336030308712,0,0,8.791335101679929,19.221722799537645,PTPRD
374,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.1135196000843595,0.1777668631108269,0,0,8.690996503496503,18.909694364771376,PTPRD
57,GO_Biological_Process_2018,regulation of actin filament-based process (GO:0032970),1/62,0.0804623654600622,0.1783450994109526,0,0,12.554854981084487,31.63780409264908,RHOJ
58,GO_Biological_Process_2018,kidney development (GO:0001822),1/63,0.0817075991872228,0.1783450994109526,0,0,12.351736972704714,30.936262547654483,ROBO2
59,GO_Biological_Process_2018,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/64,0.08295120902835,0.1783450994109526,0,0,12.155067155067156,30.260072343994267,ROBO2
380,GO_Biological_Process_2017b,negative regulation of neuron migration (GO:2001223),1/92,0.1171211806065414,0.1788406409261711,0,0,8.403212172442942,18.021076299478864,TCAF1
379,GO_Biological_Process_2017b,negative regulation of cell cycle (GO:0045786),1/92,0.1171211806065414,0.1788406409261711,0,0,8.403212172442942,18.021076299478864,MECOM
377,GO_Biological_Process_2017b,regulation of mitotic cell cycle (GO:0007346),1/92,0.1171211806065414,0.1788406409261711,0,0,8.403212172442942,18.021076299478864,MECOM
376,GO_Biological_Process_2017b,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/91,0.1159222222375367,0.1788406409261711,0,0,8.497008547008546,18.309658301022694,RNF213
378,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.1171211806065414,0.1788406409261711,0,0,8.403212172442942,18.021076299478864,PTPRD
375,GO_Biological_Process_2017b,vascular endothelial growth factor signaling pathway (GO:0038084),1/90,0.1147216960468249,0.1788406409261711,0,0,8.592912705272257,18.605770877493573,GFRA2
387,GO_Biological_Process_2017b,central nervous system maturation (GO:0021626),1/95,0.1207086685804017,0.1791160888612413,0,0,8.13379705400982,17.197899864655323,ROBO2
386,GO_Biological_Process_2017b,negative regulation of epithelial cell migration (GO:0010633),1/95,0.1207086685804017,0.1791160888612413,0,0,8.13379705400982,17.197899864655323,TCAF1
384,GO_Biological_Process_2017b,central nervous system segmentation (GO:0035283),1/95,0.1207086685804017,0.1791160888612413,0,0,8.13379705400982,17.197899864655323,ROBO2
383,GO_Biological_Process_2017b,axonogenesis (GO:0007409),1/95,0.1207086685804017,0.1791160888612413,0,0,8.13379705400982,17.197899864655323,LRFN2
382,GO_Biological_Process_2017b,larval central nervous system remodeling (GO:0035193),1/95,0.1207086685804017,0.1791160888612413,0,0,8.13379705400982,17.197899864655323,ROBO2
381,GO_Biological_Process_2017b,brain morphogenesis (GO:0048854),1/94,0.1195144018245045,0.1791160888612413,0,0,8.221670802315964,17.465446543649804,ROBO2
385,GO_Biological_Process_2017b,ventral cord development (GO:0007419),1/95,0.1207086685804017,0.1791160888612413,0,0,8.13379705400982,17.197899864655323,ROBO2
388,GO_Biological_Process_2017b,preganglionic parasympathetic fiber development (GO:0021783),1/96,0.1219013753793836,0.180159462408085,0,0,8.047773279352226,16.936884596393483,ROBO2
389,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.1230925242003742,0.1811921956229509,0,0,7.963541666666667,16.68217820842729,PTPRD
390,GO_Biological_Process_2017b,neuron projection development (GO:0031175),1/99,0.1254701557147521,0.1839562442351743,0,0,7.800235478806908,16.19085012410627,STMN4
391,GO_Biological_Process_2017b,positive regulation of axon extension (GO:0045773),1/100,0.1266566423028266,0.1849589062200008,0,0,7.721056721056721,15.953830010816358,ROBO2
395,GO_Biological_Process_2017b,neuron projection morphogenesis (GO:0048812),1/104,0.1313871063469724,0.1888689653737729,0,0,7.419716206123973,15.059110197836317,STMN4
394,GO_Biological_Process_2017b,spinal cord development (GO:0021510),1/104,0.1313871063469724,0.1888689653737729,0,0,7.419716206123973,15.059110197836317,ROBO2
393,GO_Biological_Process_2017b,oligodendrocyte differentiation (GO:0048709),1/104,0.1313871063469724,0.1888689653737729,0,0,7.419716206123973,15.059110197836317,ROBO2
392,GO_Biological_Process_2017b,astrocyte differentiation (GO:0048708),1/103,0.1302068087941927,0.1888689653737729,0,0,7.492835595776772,15.27512883928758,ROBO2
60,GO_Biological_Process_2018,Rho protein signal transduction (GO:0007266),1/72,0.0928418711410691,0.1931709899548052,0,0,10.781148429035753,25.62525396907896,RHOJ
61,GO_Biological_Process_2018,regulation of fat cell differentiation (GO:0045598),1/72,0.0928418711410691,0.1931709899548052,0,0,10.781148429035753,25.62525396907896,TRIO
62,GO_Biological_Process_2018,regulation of actin cytoskeleton organization (GO:0032956),1/75,0.0965243203976375,0.1976450370046864,0,0,10.342515592515593,24.18039062518233,RHOJ
396,GO_Biological_Process_2017b,microglia differentiation (GO:0014004),1/110,0.1384365690381021,0.1982282389339361,0,0,7.009174311926605,13.859542066692878,ROBO2
398,GO_Biological_Process_2017b,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/112,0.1407741229072719,0.2000188310033825,0,0,6.882189882189882,13.4932121116735,GFRA2
397,GO_Biological_Process_2017b,establishment of endothelial blood-brain barrier (GO:0014045),1/112,0.1407741229072719,0.2000188310033825,0,0,6.882189882189882,13.4932121116735,ROBO2
63,GO_Biological_Process_2018,cellular response to hormone stimulus (GO:0032870),1/80,0.1026297699643217,0.2060945340012569,0,0,9.685491723466408,22.05025422007099,ROBO2
64,GO_Biological_Process_2018,negative regulation of cell death (GO:0060548),1/81,0.1038460830238891,0.2060945340012569,0,0,9.563942307692308,21.66085119098212,MECOM
65,GO_Biological_Process_2018,regulation of intracellular signal transduction (GO:1902531),2/422,0.1104221173456083,0.2139295392241493,0,0,3.724380952380952,8.206467943035731,TRIO;RHOJ
66,GO_Biological_Process_2018,positive regulation of cellular component biogenesis (GO:0044089),1/87,0.1111106909148682,0.2139295392241493,0,0,8.894007155635062,19.54216474848468,PTPRD
399,GO_Biological_Process_2017b,regulation of cytoskeleton polarization involved in growth plate cartilage chondrocyte division (GO:0003427),1/122,0.1523705809293584,0.2156629760846304,0,0,6.310235219326128,11.872327013082293,STMN4
71,GO_Biological_Process_2018,cell morphogenesis involved in neuron differentiation (GO:0048667),1/97,0.1230925242003742,0.2175196660527162,0,0,7.963541666666667,16.68217820842729,LRFN2
72,GO_Biological_Process_2018,positive regulation of neuron projection development (GO:0010976),1/97,0.1230925242003742,0.2175196660527162,0,0,7.963541666666667,16.68217820842729,ROBO2
67,GO_Biological_Process_2018,regulation of JNK cascade (GO:0046328),1/90,0.1147216960468249,0.2175196660527162,0,0,8.592912705272257,18.605770877493573,MECOM
68,GO_Biological_Process_2018,axon development (GO:0061564),1/94,0.1195144018245045,0.2175196660527162,0,0,8.221670802315964,17.465446543649804,LRFN2
70,GO_Biological_Process_2018,negative regulation of cell motility (GO:2000146),1/97,0.1230925242003742,0.2175196660527162,0,0,7.963541666666667,16.68217820842729,TCAF1
69,GO_Biological_Process_2018,positive regulation of protein localization to membrane (GO:1905477),1/95,0.1207086685804017,0.2175196660527162,0,0,8.13379705400982,17.197899864655323,TCAF1
73,GO_Biological_Process_2018,nervous system development (GO:0007399),2/455,0.1250159236915863,0.2179331642731707,0,0,3.4472406181015454,7.167896231043711,ROBO2;GFRA2
400,GO_Biological_Process_2017b,negative regulation of cell migration (GO:0030336),1/126,0.1569668370758771,0.2204725039844381,0,0,6.107076923076924,11.308600906176348,TCAF1
401,GO_Biological_Process_2017b,protein homotrimerization (GO:0070207),1/126,0.1569668370758771,0.2204725039844381,0,0,6.107076923076924,11.308600906176348,RNF213
138,WikiPathways_2019_Human,Insulin Signaling WP481,1/160,0.1950778943387402,0.2275908767285303,0,0,4.792936623125303,7.833366366967883,RHOJ
136,WikiPathways_2019_Human,Endoderm Differentiation WP2853,1/141,0.1739899869025282,0.2275908767285303,0,0,5.448626373626373,9.528326387924151,TOX
137,WikiPathways_2019_Human,Mesodermal Commitment Pathway WP2857,1/147,0.180706143987249,0.2275908767285303,0,0,5.223129610115912,8.936164079429538,TOX
402,GO_Biological_Process_2017b,dendritic spine morphogenesis (GO:0060997),1/131,0.1626784146304865,0.2276260706616693,0,0,5.870710059171597,10.661091720478288,STMN4
403,GO_Biological_Process_2017b,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/133,0.1649525962977769,0.2299339221120526,0,0,5.781177156177156,10.418242827789005,GFRA2
74,GO_Biological_Process_2018,positive regulation of cellular component organization (GO:0051130),1/106,0.1337430762062543,0.2300380910747574,0,0,7.277655677655678,14.6414399447917,PTPRD
75,GO_Biological_Process_2018,regulation of organelle organization (GO:0033043),1/113,0.1419406084517323,0.2408282716142193,0,0,6.820398351648351,13.315781254294896,STMN4
76,GO_Biological_Process_2018,chromatin remodeling (GO:0006338),1/116,0.1454309224745454,0.2408282716142193,0,0,6.641471571906354,12.805116260001064,TOX
77,GO_Biological_Process_2018,plasma membrane bounded cell projection organization (GO:0120036),1/118,0.1477501988024318,0.2408282716142193,0,0,6.527284681130835,12.481684449498475,STMN4
78,GO_Biological_Process_2018,brain development (GO:0007420),1/119,0.1489075627862289,0.2408282716142193,0,0,6.4716427640156455,12.32478771385482,ROBO2
79,GO_Biological_Process_2018,actin filament organization (GO:0007015),1/120,0.1500634132130179,0.2408282716142193,0,0,6.4169360051713,12.170985320206372,RHOJ
80,GO_Biological_Process_2018,negative regulation of cell migration (GO:0030336),1/121,0.1512177519438121,0.2408282716142193,0,0,6.363141025641026,12.020192385523371,TCAF1
83,GO_Biological_Process_2018,cytoskeleton organization (GO:0007010),1/126,0.1569668370758771,0.2410562140808113,0,0,6.107076923076924,11.308600906176348,RHOJ
82,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.1558200282226172,0.2410562140808113,0,0,6.156637717121588,11.445519530111168,PTPRD
81,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.154671717152568,0.2410562140808113,0,0,6.2070043777360855,11.585065567472158,PTPRD
85,GO_Biological_Process_2018,generation of neurons (GO:0048699),1/130,0.1615390884057056,0.2423086326085584,0,0,5.916517590936196,10.785859682184276,PTPRD
84,GO_Biological_Process_2018,regulation of macromolecule metabolic process (GO:0060255),1/129,0.1603982694288782,0.2423086326085584,0,0,5.963040865384615,10.912933494989383,PRDM10
86,GO_Biological_Process_2018,cellular response to organic substance (GO:0071310),1/133,0.1649525962977769,0.2445848841656692,0,0,5.781177156177156,10.418242827789005,ROBO2
87,GO_Biological_Process_2018,neuron differentiation (GO:0030182),1/139,0.1717395098007441,0.2517545086851817,0,0,5.528149386845039,9.739363280494818,PTPRD
88,GO_Biological_Process_2018,modification-dependent protein catabolic process (GO:0019941),1/141,0.1739899869025282,0.2521877338250128,0,0,5.448626373626373,9.528326387924151,RNF213
89,GO_Biological_Process_2018,neuron development (GO:0048666),1/144,0.1773546654788057,0.2542083538529549,0,0,5.3335126412049485,9.22486368618758,STMN4
404,GO_Biological_Process_2017b,protein homooligomerization (GO:0051260),1/150,0.1840444721732586,0.2555787387160723,0,0,5.117191533298916,8.66124506385244,RNF213
405,GO_Biological_Process_2017b,ephrin receptor signaling pathway (GO:0048013),1/151,0.1851543345696807,0.2561533651189568,0,0,5.082820512820513,8.572510028509376,GFRA2
90,GO_Biological_Process_2018,negative regulation of cell differentiation (GO:0045596),1/150,0.1840444721732586,0.260898207806048,0,0,5.117191533298916,8.66124506385244,TRIO
91,GO_Biological_Process_2018,positive regulation of intracellular protein transport (GO:0090316),1/152,0.1862627431239838,0.2611727593803686,0,0,5.04890473764646,8.485174178626355,TCAF1
406,GO_Biological_Process_2017b,protein arginylation (GO:0016598),1/155,0.1895792643766286,0.2612927688786492,0,0,4.9498001998002,8.231260640854018,RNF213
407,GO_Biological_Process_2017b,Kit signaling pathway (GO:0038109),1/163,0.198359809064203,0.272374663192637,0,0,4.70346628679962,7.608668913145152,GFRA2
139,WikiPathways_2019_Human,VEGFA-VEGFR2 Signaling Pathway WP3888,1/236,0.2743617995995754,0.2743617995995754,0,0,3.2304418985270047,4.177955081688218,RHOJ
92,GO_Biological_Process_2018,neuron projection morphogenesis (GO:0048812),1/163,0.198359809064203,0.2751442512826043,0,0,4.70346628679962,7.608668913145152,LRFN2
408,GO_Biological_Process_2017b,fibroblast growth factor receptor signaling pathway (GO:0008543),1/166,0.2016288360937524,0.2758342441728657,0,0,4.617249417249417,7.393724850129072,GFRA2
93,GO_Biological_Process_2018,neuron projection development (GO:0031175),1/167,0.2027156562435052,0.2781948899511933,0,0,4.589202965708989,7.324143016476034,STMN4
409,GO_Biological_Process_2017b,protein homotetramerization (GO:0051289),1/173,0.2092067199522305,0.285141010897855,0,0,4.427772808586762,6.9269513530156175,RNF213
94,GO_Biological_Process_2018,negative regulation of Wnt signaling pathway (GO:0030178),1/174,0.2102836044169887,0.2855429996820162,0,0,4.401956425077812,6.863962563453386,RNF213
410,GO_Biological_Process_2017b,brain development (GO:0007420),1/174,0.2102836044169887,0.2855511676215935,0,0,4.401956425077812,6.863962563453386,ROBO2
411,GO_Biological_Process_2017b,insulin receptor signaling pathway (GO:0008286),1/177,0.2135057915178314,0.288860776759419,0,0,4.3262674825174825,6.680152068333892,GFRA2
95,GO_Biological_Process_2018,phosphate-containing compound metabolic process (GO:0006796),1/183,0.219912227286928,0.2955070554168096,0,0,4.182375316990702,6.334319417895495,PTPRD
412,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.2230965714792827,0.300730909539839,0,0,4.113929313929314,6.171513303628148,PTPRD
96,GO_Biological_Process_2018,protein homooligomerization (GO:0051260),1/190,0.22732289782199,0.3023160187529558,0,0,4.026048026048026,5.964122383673828,RNF213
99,GO_Biological_Process_2018,protein oligomerization (GO:0051259),1/217,0.2552769580979776,0.3293072759463911,0,0,3.5179843304843303,4.803477662173212,RNF213
98,GO_Biological_Process_2018,central nervous system development (GO:0007417),1/217,0.2552769580979776,0.3293072759463911,0,0,3.5179843304843303,4.803477662173212,ROBO2
97,GO_Biological_Process_2018,regulation of cell cycle (GO:0051726),1/215,0.253240138459512,0.3293072759463911,0,0,3.551222142343638,4.877309132932216,MECOM
100,GO_Biological_Process_2018,Ras protein signal transduction (GO:0007265),1/223,0.2613553692045386,0.3338103230434206,0,0,3.421864171864172,4.59171135050736,RHOJ
413,GO_Biological_Process_2017b,protein K33-linked ubiquitination (GO:1990390),1/214,0.2522197180550142,0.3367359757930964,0,0,3.568075117370892,4.914861748706164,RNF213
414,GO_Biological_Process_2017b,protein linear polyubiquitination (GO:0097039),1/214,0.2522197180550142,0.3367359757930964,0,0,3.568075117370892,4.914861748706164,RNF213
415,GO_Biological_Process_2017b,protein K27-linked ubiquitination (GO:0044314),1/217,0.2552769580979776,0.3367359757930964,0,0,3.5179843304843303,4.803477662173212,RNF213
416,GO_Biological_Process_2017b,protein K29-linked ubiquitination (GO:0035519),1/217,0.2552769580979776,0.3367359757930964,0,0,3.5179843304843303,4.803477662173212,RNF213
417,GO_Biological_Process_2017b,protein K6-linked ubiquitination (GO:0085020),1/220,0.2583221599635696,0.3367359757930964,0,0,3.469265893923428,4.695817187063847,RNF213
418,GO_Biological_Process_2017b,actin ubiquitination (GO:0007014),1/226,0.2643766313096846,0.3367359757930964,0,0,3.375726495726496,4.491000901612669,RNF213
419,GO_Biological_Process_2017b,protein ubiquitination (GO:0016567),1/226,0.2643766313096846,0.3367359757930964,0,0,3.375726495726496,4.491000901612669,RNF213
423,GO_Biological_Process_2017b,MAPK cascade involved in osmosensory signaling pathway (GO:0000161),1/232,0.2703834948505306,0.3367359757930964,0,0,3.287046287046287,4.299173780001111,GFRA2
422,GO_Biological_Process_2017b,ERK5 cascade (GO:0070375),1/232,0.2703834948505306,0.3367359757930964,0,0,3.287046287046287,4.299173780001111,GFRA2
441,GO_Biological_Process_2017b,protein K63-linked ubiquitination (GO:0070534),1/238,0.2763431105693346,0.3367359757930964,0,0,3.2028562155144438,4.119231912671557,RNF213
440,GO_Biological_Process_2017b,positive regulation of fibroblast apoptotic process (GO:2000271),1/238,0.2763431105693346,0.3367359757930964,0,0,3.2028562155144438,4.119231912671557,TRIO
439,GO_Biological_Process_2017b,MAPK cascade involved in axon regeneration (GO:1903616),1/237,0.275353107168646,0.3367359757930964,0,0,3.2165906127770536,4.14844006203277,GFRA2
438,GO_Biological_Process_2017b,protein monoubiquitination (GO:0006513),1/237,0.275353107168646,0.3367359757930964,0,0,3.2165906127770536,4.14844006203277,RNF213
437,GO_Biological_Process_2017b,protein K11-linked ubiquitination (GO:0070979),1/236,0.2743617995995754,0.3367359757930964,0,0,3.2304418985270047,4.177955081688218,RNF213
436,GO_Biological_Process_2017b,histone ubiquitination (GO:0016574),1/235,0.2733691862552349,0.3367359757930964,0,0,3.2444115713346484,4.207781404655145,RNF213
434,GO_Biological_Process_2017b,positive regulation of mesenchymal cell apoptotic process (GO:2001055),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
433,GO_Biological_Process_2017b,positive regulation of leukocyte apoptotic process (GO:2000108),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
432,GO_Biological_Process_2017b,positive regulation of glial cell apoptotic process (GO:0034352),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
431,GO_Biological_Process_2017b,positive regulation of muscle cell apoptotic process (GO:0010661),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
430,GO_Biological_Process_2017b,positive regulation of myofibroblast cell apoptotic process (GO:1904522),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
429,GO_Biological_Process_2017b,positive regulation of epithelial cell apoptotic process (GO:1904037),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
428,GO_Biological_Process_2017b,positive regulation of apoptotic process involved in development (GO:1904747),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
427,GO_Biological_Process_2017b,positive regulation of compound eye retinal cell apoptotic process (GO:1901694),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
426,GO_Biological_Process_2017b,positive regulation of fat cell apoptotic process (GO:1904651),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
425,GO_Biological_Process_2017b,positive regulation of apoptotic process in other organism (GO:0044533),1/234,0.2723752654580872,0.3367359757930964,0,0,3.258501155496864,4.237923547270316,TRIO
424,GO_Biological_Process_2017b,MAPK cascade involved in innate immune response (GO:0035420),1/232,0.2703834948505306,0.3367359757930964,0,0,3.287046287046287,4.299173780001111,GFRA2
420,GO_Biological_Process_2017b,isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276),1/226,0.2643766313096846,0.3367359757930964,0,0,3.375726495726496,4.491000901612669,RNF213
435,GO_Biological_Process_2017b,positive regulation of myeloid cell apoptotic process (GO:0033034),1/235,0.2733691862552349,0.3367359757930964,0,0,3.2444115713346484,4.207781404655145,TRIO
421,GO_Biological_Process_2017b,MAPK cascade (GO:0000165),1/232,0.2703834948505306,0.3367359757930964,0,0,3.287046287046287,4.299173780001111,GFRA2
442,GO_Biological_Process_2017b,positive regulation of anoikis (GO:2000210),1/240,0.2783192114594731,0.3380246528616702,0,0,3.1757322175732217,4.061718892262195,TRIO
443,GO_Biological_Process_2017b,positive regulation of execution phase of apoptosis (GO:1900119),1/241,0.2793053123014996,0.3381064306807627,0,0,3.162339743589744,4.033405549715393,TRIO
444,GO_Biological_Process_2017b,protein K48-linked ubiquitination (GO:0070936),1/243,0.2812736228674473,0.3393727646400675,0,0,3.135886840432295,3.977644592804115,RNF213
445,GO_Biological_Process_2017b,ERK1 and ERK2 cascade (GO:0070371),1/245,0.2832367563329104,0.3406245958513432,0,0,3.1098675914249685,3.9230113140821192,GFRA2
446,GO_Biological_Process_2017b,positive regulation of apoptotic signaling pathway (GO:2001235),1/248,0.2861717779798696,0.343033271324404,0,0,3.071628776082217,3.843108354712212,TRIO
447,GO_Biological_Process_2017b,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/249,0.2871475441165661,0.343085377386027,0,0,3.0590880893300247,3.81700501438922,RNF213
448,GO_Biological_Process_2017b,stress-activated MAPK cascade (GO:0051403),1/250,0.2881220257982156,0.3431356164846063,0,0,3.0466481309854805,3.791161153848622,GFRA2
449,GO_Biological_Process_2017b,protein autoubiquitination (GO:0051865),1/253,0.291037780091971,0.34549000991563,0,0,3.009920634920635,3.715151636654686,RNF213
450,GO_Biological_Process_2017b,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/258,0.2958718322312361,0.3500991455340672,0,0,2.9506135887458846,3.593342553180191,TRIO
451,GO_Biological_Process_2017b,positive regulation of neuron apoptotic process (GO:0043525),1/270,0.3073444061574051,0.3625087867497599,0,0,2.8172719473834715,3.3237788920608606,TRIO
452,GO_Biological_Process_2017b,MAPK import into nucleus (GO:0000189),1/273,0.3101843002029492,0.3646895286731159,0,0,2.785774886877828,3.26099644000504,GFRA2
453,GO_Biological_Process_2017b,canonical Wnt signaling pathway involved in positive regulation of apoptotic process (GO:0044337),1/279,0.315830488654146,0.3701452860660054,0,0,2.724820143884892,3.1404904694524363,TRIO
101,GO_Biological_Process_2018,positive regulation of programmed cell death (GO:0043068),1/257,0.2949075680993878,0.3729713361256964,0,0,2.9622896634615383,3.617232061353747,TRIO
102,GO_Biological_Process_2018,endocytosis (GO:0006897),1/263,0.3006741361609286,0.3765724617937844,0,0,2.8935701702877274,3.477284886170601,RHOJ
103,GO_Biological_Process_2018,regulation of programmed cell death (GO:0043067),1/268,0.3054448923258123,0.3788691452887479,0,0,2.8386632094497264,3.36661454644352,MECOM
454,GO_Biological_Process_2017b,protein polyubiquitination involved in nucleus-associated proteasomal ubiquitin-dependent protein catabolic process (GO:1901044),1/292,0.3279116312843493,0.3830840644845731,0,0,2.6013745704467355,2.9005615829928404,RNF213
104,GO_Biological_Process_2018,MAPK cascade (GO:0000165),1/278,0.3148925577840943,0.3868679995633159,0,0,2.734795890030547,3.160121697337857,GFRA2
105,GO_Biological_Process_2018,protein polyubiquitination (GO:0000209),1/283,0.3195698620513116,0.3889104924964075,0,0,2.6856246590289143,3.063705202554494,RNF213
129,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0977486015575413,0.3909944062301654,0,0,10.204102564102564,23.72817506630132,MECOM
106,GO_Biological_Process_2018,positive regulation of apoptotic process (GO:0043065),1/307,0.3415961918263038,0.4118309228560112,0,0,2.4719708396178985,2.6552080639997198,TRIO
107,GO_Biological_Process_2018,regulation of cell migration (GO:0030334),1/316,0.3496777128248833,0.4176706014297218,0,0,2.4002442002442,2.522040677902503,TCAF1
455,GO_Biological_Process_2017b,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),1/329,0.3611825909110406,0.4206177008077941,0,0,2.30358818011257,2.3459089109247486,RNF213
456,GO_Biological_Process_2017b,central nervous system development (GO:0007417),1/333,0.3646829461405195,0.4233543349517704,0,0,2.2753707136237256,2.295227745504945,ROBO2
457,GO_Biological_Process_2017b,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),1/344,0.3742139515237423,0.4330526231469722,0,0,2.2011661807580176,2.16358695215103,RNF213
130,KEGG_2019_Human,Axon guidance,1/181,0.2177823526979322,0.4355647053958645,0,0,4.229273504273504,6.4465086127084605,ROBO2
108,GO_Biological_Process_2018,ubiquitin-dependent protein catabolic process (GO:0006511),1/341,0.3716283302936751,0.4398170147512302,0,0,2.220927601809955,2.1984096974037404,RNF213
131,KEGG_2019_Human,MAPK signaling pathway,1/295,0.3306702713379863,0.4408936951173151,0,0,2.57443746729461,2.848958897372753,MECOM
458,GO_Biological_Process_2017b,torso signaling pathway (GO:0008293),1/371,0.3970280912531306,0.4580135974330785,0,0,2.0377338877338875,1.8823530964054864,GFRA2
459,GO_Biological_Process_2017b,positive regulation of apoptotic process (GO:0043065),1/374,0.3995129844107229,0.4594399320723313,0,0,2.0210352650030936,1.8543180705240223,TRIO
460,GO_Biological_Process_2017b,protein polyubiquitination (GO:0000209),1/381,0.405272778598425,0.4646117835645495,0,0,1.9830971659919028,1.7911232687189322,RNF213
461,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),1/387,0.4101673682862325,0.4687627066128371,0,0,1.951673973694699,1.7393123037306373,PTPRD
462,GO_Biological_Process_2017b,negative regulation of ncRNA transcription associated with protein coding gene TSS/TES (GO:1904388),1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
463,GO_Biological_Process_2017b,nitrogen catabolite repression of transcription (GO:0090295),1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
464,GO_Biological_Process_2017b,negative regulation of antisense RNA transcription (GO:0060195),1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
465,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase V promoter (GO:1904280),1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
466,GO_Biological_Process_2017b,"negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated (GO:0010678)",1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
467,GO_Biological_Process_2017b,negative regulation of transcription by pheromones (GO:0045996),1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
468,GO_Biological_Process_2017b,"negative regulation of mating-type specific transcription, DNA-templated (GO:0045894)",1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
469,GO_Biological_Process_2017b,negative regulation of transcription during mitotic cell cycle (GO:0007068),1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
472,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor catabolism (GO:0010620),1/413,0.430932656844107,0.4742444505811485,0,0,1.8260828976848396,1.5372028827239483,MECOM
473,GO_Biological_Process_2017b,carbon catabolite repression of transcription (GO:0045013),1/413,0.430932656844107,0.4742444505811485,0,0,1.8260828976848396,1.5372028827239483,MECOM
474,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, termination (GO:0060567)",1/414,0.4317170949583824,0.4742444505811485,0,0,1.8215682622462284,1.5300896124519614,MECOM
471,GO_Biological_Process_2017b,negative regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090419),1/413,0.430932656844107,0.4742444505811485,0,0,1.8260828976848396,1.5372028827239483,MECOM
470,GO_Biological_Process_2017b,chromatin organization involved in negative regulation of transcription (GO:0097549),1/412,0.4301471761265089,0.4742444505811485,0,0,1.8306195021523488,1.54436161086717,MECOM
475,GO_Biological_Process_2017b,negative regulation of transcription by competitive promoter binding (GO:0010944),1/416,0.4332828484457046,0.4745478816310098,0,0,1.8126042632066728,1.5159979209646472,MECOM
476,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),1/419,0.4356236920033861,0.4756959010600773,0,0,1.799319101950681,1.4951918898059322,MECOM
477,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/422,0.4379552232567644,0.4756989033233121,0,0,1.786223277909739,1.4747748933179785,MECOM
478,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase III promoter (GO:0016480),1/423,0.4387303371298048,0.4756989033233121,0,0,1.7818993802406125,1.4680540141477598,MECOM
479,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, initiation (GO:2000143)",1/424,0.4395044215487123,0.4756989033233121,0,0,1.7775959265320966,1.461374945839452,MECOM
480,GO_Biological_Process_2017b,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),1/430,0.4441273838556699,0.4792928951873504,0,0,1.7521965214272908,1.4221595430873115,MECOM
481,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor localization (GO:0010621),1/432,0.4456601953506724,0.4795407949972147,0,0,1.743887203283955,1.4094070413656286,MECOM
109,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),2/1037,0.4118898800510054,0.4826445366996858,0,0,1.4638067632850242,1.2983954964773723,TOX;PRDM10
110,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/396,0.4174365909379463,0.4826445366996858,0,0,1.9063291139240504,1.6654122431310292,GFRA2
111,GO_Biological_Process_2018,protein modification by small protein conjugation (GO:0032446),1/398,0.4190402179098048,0.4826445366996858,0,0,1.896531679906995,1.6495812140738464,RNF213
112,GO_Biological_Process_2018,negative regulation of programmed cell death (GO:0043069),1/408,0.4269947999793887,0.4849642762962786,0,0,1.848988848988849,1.5734588983747515,MECOM
113,GO_Biological_Process_2018,vesicle-mediated transport (GO:0016192),1/410,0.4285730813781067,0.4849642762962786,0,0,1.839759262742148,1.5588169918410526,RHOJ
482,GO_Biological_Process_2017b,negative regulation of apoptotic process (GO:0043066),1/467,0.4718346372798206,0.4941645044135529,0,0,1.610019808517663,1.2093288649462246,MECOM
484,GO_Biological_Process_2017b,positive regulation of antisense RNA transcription (GO:0060196),1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
483,GO_Biological_Process_2017b,positive regulation of transcription from a mobile element promoter (GO:0061435),1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
487,GO_Biological_Process_2017b,positive regulation of transcription during mitotic cell cycle (GO:0045897),1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
488,GO_Biological_Process_2017b,nitrogen catabolite activation of transcription (GO:0090294),1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
489,GO_Biological_Process_2017b,positive regulation of chromatin-mediated maintenance of transcription (GO:1904501),1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
490,GO_Biological_Process_2017b,"positive regulation of mating-type specific transcription, DNA-templated (GO:0045895)",1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
485,GO_Biological_Process_2017b,positive regulation of transcription by pheromones (GO:0009371),1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
491,GO_Biological_Process_2017b,positive regulation of transcription from mitochondrial promoter (GO:1903109),1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
492,GO_Biological_Process_2017b,carbon catabolite activation of transcription (GO:0045991),1/470,0.4740219295053918,0.4941645044135529,0,0,1.5994751517139576,1.1940109095902935,MECOM
486,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase V promoter (GO:1904281),1/469,0.473293803100706,0.4941645044135529,0,0,1.6029750164365548,1.1990877243166802,MECOM
493,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, termination (GO:0060566)",1/472,0.4754752755856267,0.494279382529691,0,0,1.5925200065327454,1.1839437027242654,MECOM
494,GO_Biological_Process_2017b,positive regulation of transcription involved in exit from mitosis (GO:0007072),1/481,0.4819676155387536,0.4989544450371467,0,0,1.5619391025641025,1.1400255425829633,MECOM
495,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/482,0.482684191394631,0.4989544450371467,0,0,1.558611866304174,1.1352814856391014,MECOM
496,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase III promoter (GO:0045945),1/485,0.4848281964565881,0.4991716457194114,0,0,1.5487126509853784,1.1212070715369375,MECOM
497,GO_Biological_Process_2017b,positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931),1/487,0.4862527767299325,0.4991716457194114,0,0,1.5421810699588476,1.1119536869107485,MECOM
498,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/488,0.4869636435143171,0.4991716457194114,0,0,1.538935397251619,1.1073652997561434,MECOM
499,GO_Biological_Process_2017b,positive regulation of transcription by transcription factor localization (GO:0061586),1/490,0.4883825366599355,0.4992354819190451,0,0,1.5324838760421582,1.098264214620532,MECOM
500,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/493,0.4905037933008059,0.5000149471875251,0,0,1.5229049405878674,1.0847990988945189,MECOM
501,GO_Biological_Process_2017b,negative regulation of chromatin silencing (GO:0031936),1/509,0.501674892703747,0.5099899461739749,0,0,1.4737280436099334,1.0165820156236904,MECOM
114,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),1/444,0.4547719448205017,0.5101354859290845,0,0,1.6956068761937837,1.3360690476142525,MECOM
132,KEGG_2019_Human,Pathways in cancer,1/530,0.5159794885157107,0.5159794885157107,0,0,1.4136978333575687,0.9354272669126608,MECOM
502,GO_Biological_Process_2017b,chromatin-mediated maintenance of transcription (GO:0048096),1/554,0.5318435222433334,0.5391691905937925,0,0,1.3506746418138824,0.8528240243014371,MECOM
115,GO_Biological_Process_2018,positive regulation of nucleic acid-templated transcription (GO:1903508),1/502,0.4968168690869683,0.5507021458383439,0,0,1.494856440964225,1.0457025968112832,MECOM
116,GO_Biological_Process_2018,protein ubiquitination (GO:0016567),1/506,0.499598438698695,0.5507021458383439,0,0,1.4827113480578826,1.028928467922302,RNF213
117,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/512,0.5037430481311983,0.5507021458383439,0,0,1.4648502182748755,1.00443163159039,MECOM
118,GO_Biological_Process_2018,regulation of nucleic acid-templated transcription (GO:1903506),1/607,0.5651224277066889,0.6126117073459064,0,0,1.2291825336379791,0.7015103100898029,TOX
119,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),1/618,0.5717379990134589,0.6146183489394683,0,0,1.2065827203590576,0.6745695541365145,MECOM
120,GO_Biological_Process_2018,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/631,0.5794314932688535,0.617741013484976,0,0,1.180891330891331,0.6444216576389254,TOX
503,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),1/770,0.6538005438501805,0.6609851652111715,0,0,0.9604881464439332,0.4081622740210583,PTPRD
121,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",2/1598,0.6470898222263025,0.6842179267802707,0,0,0.9211528822055138,0.4009503673302708,MECOM;TOX
122,GO_Biological_Process_2018,positive regulation of gene expression (GO:0010628),1/771,0.6542866255351798,0.6862030462929934,0,0,0.9591908091908092,0.4068981012257014,MECOM
123,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",1/813,0.6741189807247732,0.6966366534989825,0,0,0.9075881015536188,0.3579061465826397,MECOM
124,GO_Biological_Process_2018,regulation of apoptotic process (GO:0042981),1/815,0.6750355169563784,0.6966366534989825,0,0,0.9052636552636552,0.3557595383361729,TRIO
125,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/848,0.6898047274422865,0.7062286495242457,0,0,0.868495141222414,0.3225128265022982,MECOM
504,GO_Biological_Process_2017b,"negative regulation of transcription, DNA-templated (GO:0045892)",1/895,0.7097286006613592,0.7155619864202197,0,0,0.8208139734985372,0.2814346496210643,MECOM
505,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/991,0.7466654702979465,0.7507456094799025,0,0,0.7374902874902874,0.2154489561045548,MECOM
506,GO_Biological_Process_2017b,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1004,0.7513050441886908,0.7533521968976518,0,0,0.7274330853593067,0.2080047811254833,MECOM
126,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),1/1001,0.7502416917264013,0.7620565215173682,0,0,0.7297307692307692,0.2096953380542307,PTPRD
127,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1120,0.7892374393377507,0.7954033568325769,0,0,0.6480373960266722,0.1533827181893499,MECOM
507,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/1175,0.8052125506702598,0.8052125506702598,0,0,0.6158760319748394,0.1334289254140564,MECOM
128,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),1/1478,0.8743511509414755,0.8743511509414755,0,0,0.4816415811676475,0.0646715609242304,MECOM
